Fritextsökning
Innehållstyper
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
Mingling types - who to aim for and who to avoid:
Read about different mingling types - who are you?
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Han tar plats i den virtuella ledningsgruppen
Advokaten Stefan Wendén tar plats i forskningsparken Medeons första virtuella ledningsgrupp.
-
Framåt för Sobi
Efter gårdagens kvartalsrapport som slog förväntningarna får bolagets läkemedel Alprolix godkänt i Schweiz.
-
Oasmia får FDA-ok för djurläkemedel
Godkännandet ger bolaget ekonomisk stabilitet, menar vd.
-
Han ska ta in kapital åt tillväxtbolagen
För att öka tillgången på externt kapital för tillväxtbolagen i Sahlgrenska Science Park inrättas en ny tjänst.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
How to get the most out of the fair
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Lägger ner arbetet med hjärtinfarkt
Efter negativa resultat från fas III-studien Circus avslutar Neurovive sin utveckling mot akut hjärtinfarkt.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Nya sätt att spana in i hjärnan
Avancerade metoder för att avbilda hjärnan ger forskarna nya möjligheter att förstå hur olika delar kommunicerar med varandra, hela vägen ner på cellnivå. Förho...
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...